ZDHHC6, also known as Zinc finger DHHC-type containing 6, is a member of the DHHC family of palmitoyltransferases. These enzymes catalyze the post-translational modification of proteins by adding fatty acyl groups, such as palmitate, onto cysteine residues. ZDHHC6 specifically mediates the palmitoylation of target proteins, thereby regulating their localization, stability, and function within cells. Palmitoylation is a reversible modification that plays critical roles in various cellular processes, including signal transduction, membrane trafficking, and protein-protein interactions. As such, ZDHHC6 serves as a key regulator of protein palmitoylation and contributes to the dynamic regulation of cellular functions.
Activation of ZDHHC6 is orchestrated by multiple factors and mechanisms that control its enzymatic activity and substrate specificity. One major regulatory mechanism involves the post-translational modifications and protein-protein interactions that modulate ZDHHC6 function. For instance, phosphorylation events mediated by kinases can either enhance or inhibit ZDHHC6 activity, depending on the specific residues targeted and the cellular context. Additionally, binding partners or scaffolding proteins may facilitate the recruitment of ZDHHC6 to specific subcellular compartments or protein complexes, thereby promoting its enzymatic activity towards specific substrates. Furthermore, changes in cellular signaling pathways or environmental cues can influence ZDHHC6 expression levels or subcellular localization, thereby regulating its availability and activity. Overall, elucidating the mechanisms of ZDHHC6 activation provides valuable insights into the regulation of protein palmitoylation and its implications for cellular physiology and pathophysiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which can phosphorylate ZDHHC6, enhancing its palmitoyltransferase activity. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $32.00 $75.00 $118.00 | 14 | |
FTY720 is phosphorylated in vivo to form FTY720-P, an agonist at sphingosine-1-phosphate receptors. This agonism can lead to downstream activation of signaling pathways that could result in the translocation and enhancement of ZDHHC6 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which may activate calcium-dependent proteins that associate with ZDHHC6, potentially enhancing its enzymatic function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA directly activates protein kinase C (PKC), which may phosphorylate and enhance ZDHHC6 activity or its substrate specificity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium which may stimulate calcium-dependent pathways that activate ZDHHC6. | ||||||
Oleylethanolamide | 111-58-0 | sc-201400 sc-201400A | 10 mg 50 mg | $88.00 $190.00 | 1 | |
OEA activates peroxisome proliferator-activated receptor-alpha (PPAR-alpha), which can lead to downstream effects on lipid signaling pathways, potentially enhancing the activity of ZDHHC6. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG inhibits certain protein kinases and might reduce competitive signaling, allowing ZDHHC6-mediated palmitoylation pathways to be more active. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
S1P binds to its receptors, initiating signaling cascades that could lead to the activation of proteins that interact with or modulate the activity of ZDHHC6. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA could lead to phosphorylation events that enhance the palmitoyltransferase activity of ZDHHC6. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I is a PKC inhibitor that could prevent PKC from phosphorylating proteins that negatively regulate ZDHHC6, thus indirectly increasing ZDHHC6 activity. | ||||||